Covid and potential therapies, here is SAVE-MORE. The title is promising, authoritative editing of the study (Nature Medicine), the molecule (monoclonal antibody) object of the research that led to yet another result is well known. Optimistic of course, but for which it would be a mistake, as experience teaches, to claim victory.
What it is and how it works
Anakinra, this is the name of the drug, would be useful not only for the treatment of rheumatoid arthritis (for which it has been authorized in the European Union since 2002), but also for the treatment of Sars-Cov-2.